Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Lemonade, Inc.Lemonade Reports 42% Revenue Growth to $194.5 Million in Latest Quarter
PLUMAS BANCORPPlumas Bancorp Reports $5.1 Million Net Income and Significant Asset Growth Following Cornerstone Acquisition
CHS INCCHS Inc. Reports $35.5 Billion Revenue and $597.9 Million Net Income for Fiscal Year 2025
Eagle Bancorp Montana, Inc.Eagle Bancorp Montana Reports 34% Increase in Net Income for Q3 2025
Andersons, Inc.The Andersons, Inc. Reports Q3 2025 Financial Results with Revenue Increase but Declining Net Income
SILGAN HOLDINGS INCSilgan Holdings Reports 15.1% Revenue Growth to $2.01 Billion in Q3 2025
INDEPENDENT BANK CORP /MI/Independent Bank Corporation Reports $17.5 Million Net Income for Q3 2025
TERADATA CORP /DE/Teradata Reports Q3 2025 Revenue Decline to $416 Million, Net Income Rises to $40 Million
CITY HOLDING COCity Holding Company Reports Strong Q3 and Year-to-Date Financial Performance
INNOSPEC INC.Innospec Reports Decline in Q3 and Nine-Month Financial Performance for 2025
STEPAN COStepan Company Reports Q3 2025 Results with Decline in Net Income Despite Revenue Growth
Seres Therapeutics, Inc.Seres Therapeutics Reports Q3 2025 Financial Results with Revenue of $351,000 and Net Income of $8.2 Million
Paylocity Holding CorpPaylocity Reports 12% Revenue Growth to $408.2 Million, Net Income Declines
BCB BANCORP INCBCB Bancorp Reports $498,000 Net Loss for Nine Months Ended September 30, 2025
OPENLANE, Inc.OPENLANE Reports 8% Revenue Growth to $498.4 Million in Q3 2025
Ocugen, Inc.Ocugen Reports 54.3% Revenue Increase but Wider Net Loss in Q3 2025
NATURAL HEALTH TRENDS CORPNatural Health Trends Corp. Reports Decline in Q3 2025 Financial Performance
AFLAC INCAflac Reports $4.74 Billion in Q3 2025 Revenues, Significant Earnings Recovery
HNI CORPHNI Corporation Reports 1.7% Sales Increase in Q3 2025, Announces Steelcase Acquisition
Royalty Pharma plcRoyalty Pharma Reports 7.9% Revenue Growth to $609.3 Million in Q3 2025
Tempest Therapeutics, Inc.Tempest Therapeutics Reports $3.5 Million Net Loss, Focuses on Strategic Alternatives
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.Charles River Laboratories Reports Revenue and Net Income Decline in Q3 Fiscal 2025
Elanco Animal Health IncElanco Reports $1.137 Billion Revenue in Q3 2025, Faces $34 Million Net Loss
MACERICH COMacerich Reports 15% Revenue Growth and Improved Net Loss in Q3 2025
POWER INTEGRATIONS INCPower Integrations Reports Q3 2025 Revenue Increase but Net Loss